FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The FTC has challenged biotech Amgen’s proposed $28 billion purchase of rare-disease drugmaker Horizon

, in a rare effort by antitrust enforcers to prevent a merger of pharmaceutical companies.from closing. A federal judge would need to approve the injunction. That is part of a two-step legal process the agency typically uses to prevent mergers it believes are illegal.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 413. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FTC Poised to Block Amgen’s $27.8 Billion Deal for Horizon TherapeuticsThe Federal Trade Commission is preparing to block Amgen’s $28 billion deal to buy Horizon Therapeutics
Source: WSJ - 🏆 98. / 63 Read more »